Compare AANJANEYA LIFECARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ABBOTT INDIA DR. DATSONS LABS/
ABBOTT INDIA
 
P/E (TTM) x -10.9 56.0 - View Chart
P/BV x 0.2 13.5 1.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   ABBOTT INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ABBOTT INDIA
Mar-19
DR. DATSONS LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1268,834 1.4%   
Low Rs315,458 0.6%   
Sales per share (Unadj.) Rs133.01,731.1 7.7%  
Earnings per share (Unadj.) Rs0.2211.9 0.1%  
Cash flow per share (Unadj.) Rs6.6219.9 3.0%  
Dividends per share (Unadj.) Rs065.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8945.2 13.6%  
Shares outstanding (eoy) m31.6621.25 149.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.1 14.3%   
Avg P/E ratio x516.133.7 1,530.6%  
P/CF ratio (eoy) x11.832.5 36.4%  
Price / Book Value ratio x0.67.6 8.0%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m2,477151,848 1.6%   
No. of employees `000NA3.5 0.0%   
Total wages/salary Rs m564,356 1.3%   
Avg. sales/employee Rs ThNM10,555.5-  
Avg. wages/employee Rs ThNM1,249.9-  
Avg. net profit/employee Rs ThNM1,292.2-  
INCOME DATA
Net Sales Rs m4,21136,786 11.4%  
Other income Rs m791,133 6.9%   
Total revenues Rs m4,28937,919 11.3%   
Gross profit Rs m5696,047 9.4%  
Depreciation Rs m204169 120.8%   
Interest Rs m43023 1,912.0%   
Profit before tax Rs m136,989 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,485 0.2%   
Profit after tax Rs m54,503 0.1%  
Gross profit margin %13.516.4 82.1%  
Effective tax rate %48.035.6 135.1%   
Net profit margin %0.112.2 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,85227,610 24.8%   
Current liabilities Rs m6,7118,569 78.3%   
Net working cap to sales %3.351.8 6.5%  
Current ratio x1.03.2 31.7%  
Inventory Days Days16160 267.1%  
Debtors Days Days31827 1,162.5%  
Net fixed assets Rs m3,6731,057 347.5%   
Share capital Rs m317213 149.0%   
"Free" reserves Rs m3,76119,873 18.9%   
Net worth Rs m4,07820,086 20.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63329,409 43.0%  
Interest coverage x1.0311.6 0.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.3 26.6%   
Return on assets %3.415.4 22.4%  
Return on equity %0.122.4 0.5%  
Return on capital %7.734.9 22.0%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964369 261.3%   
Fx outflow Rs m6074,918 12.3%   
Net fx Rs m357-4,549 -7.8%   
CASH FLOW
From Operations Rs m1,3454,991 26.9%  
From Investments Rs m-2,256-2,570 87.8%  
From Financial Activity Rs m-1,200-1,428 84.0%  
Net Cashflow Rs m-2,111993 -212.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 1.4 0.1 1,350.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.1 550.3%  
Shareholders   20,807 18,270 113.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Telecom and Energy Stocks Gain the Most(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.4% while the Hang Seng is down 0.7%.

Related Views on News

SANOFI INDIA at All Time High; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Nov 20, 2019 | Updated on Nov 20, 2019

SANOFI INDIA share price has hit an all time high at Rs 7,000 (up 0.6%). The BSE HEALTHCARE Index is up by 0.9%. Among the top gainers in the BSE HEALTHCARE Index today are SANOFI INDIA (up 0.6%) and ABBOTT INDIA (up 0.2%). The top losers include GSK PHARMA and J.B.CHEMICALS (down 0.2%).

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS